insights_auto
Por que DRUG subiu 4,87%?
Saiba maischevron_right
DRUG:CNSX
Bright Minds Biosciences Inc
CA$ 77,10
arrow_upward
+4,87%(+3,58) 1D
9 de out., 16:00:00 GMT-4 · CAD
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para DRUG…
Abrir
CA$ 76,13
Alta
CA$ 77,76
Baixa
CA$ 76,13
Valor de mercado
760,52 mi
Volume médio
865,00
Volume
400,00
Alto — 52 sem
CA$ 170,00
Baixo — 52 sem
CA$ 68,02
LPA
-CA$ 2,90
Nº de funcionários
26
Abrir
CA$ 76,13
Alta
CA$ 77,76
Baixa
CA$ 76,13
Valor de mercado
760,52 mi
Volume médio
865,00
Volume
400,00
Alto — 52 sem
CA$ 170,00
Baixo — 52 sem
CA$ 68,02
LPA
-CA$ 2,90
Nº de funcionários
26
Notícias
De fontes da web e parceiros de notícias
Yahoo Finance
·
há 3 dias
Bright Minds Biosciences And 2 More Canadian Biotech Stocks
Perfil
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
Sobre Bright Minds Biosciences Inc